GRAS Notices
-
GRN No. 80
ARASCO (arachidonic acid-rich single-cell oil)
Intended Use: | Provide ARASCO (as a source of arachidonic acid) in term infant formula, at a maximum level of 1.88 percent of total dietary fat when used in combination with DHASCO (docosahexaenoic acid-rich single-cell oil; as a source of docosahexaenoic acid) at a maximum level of 1.25 per cent of the total dietary fat and at a ratio ranging from 1:1 to 1:2 (DHASCO:ARASCO) |
---|---|
Basis: | Scientific procedures |
Notifier: | Mead Johnson Nutritionals |
Notifier Address: | 2400 West Lloyd Expressway, Evansville, IN 47721 |
Date of filing: | Aug 6, 2001 |
GRAS Notice (releasable information): | GRN 80 part 1 (in PDF) (5.7 MB) |
Part 2: | GRN 80 part 2 with amendments (in PDF) (6.2 MB) |
Date of closure: | Dec 11, 2001 |
FDA's Letter: | FDA has no questions |
-